D.E. Shaw & Co’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $116M | Buy |
1,617,522
+542,634
| +50% | +$41.8M | 0.07% | 325 |
|
|
2025
Q4 | $85.3M | Sell |
1,074,888
-43,255
| -4% | -$3.41M | 0.05% | 461 |
|
|
2025
Q3 | $84.3M | Buy |
1,118,143
+190,786
| +21% | +$13.1M | 0.05% | 444 |
|
|
2025
Q2 | $64M | Buy |
927,357
+572,252
| +161% | +$37.5M | 0.05% | 471 |
|
|
2025
Q1 | $24.1M | Sell |
355,105
-828,846
| -70% | -$49.6M | 0.02% | 833 |
|
|
2024
Q4 | $53.1M | Sell |
1,183,951
-2,575,354
| -69% | -$144M | 0.04% | 550 |
|
|
2024
Q3 | $236M | Buy |
3,759,305
+2,679,014
| +248% | +$156M | 0.2% | 107 |
|
|
2024
Q2 | $63.8M | Buy |
1,080,291
+980,372
| +981% | +$61.3M | 0.06% | 375 |
|
|
2024
Q1 | $7.97M | Sell |
99,919
-27,822
| -22% | -$2.13M | 0.01% | 1536 |
|
|
2023
Q4 | $10.1M | Sell |
127,741
-744,310
| -85% | -$53M | 0.01% | 1359 |
|
|
2023
Q3 | $60.9M | Sell |
872,051
-908,874
| -51% | -$64.4M | 0.06% | 365 |
|
|
2023
Q2 | $123M | Buy |
1,780,925
+309,877
| +21% | +$22M | 0.13% | 183 |
|
|
2023
Q1 | $109M | Buy |
1,471,048
+1,404,822
| +2,121% | +$118M | 0.12% | 199 |
|
|
2022
Q4 | $6.17M | Sell |
66,226
-121,349
| -65% | -$11.7M | 0.01% | 1885 |
|
|
2022
Q3 | $17.9M | Sell |
187,575
-208,168
| -53% | -$20.6M | 0.02% | 932 |
|
|
2022
Q2 | $36.7M | Buy |
395,743
+373,779
| +1,702% | +$36.5M | 0.04% | 539 |
|
|
2022
Q1 | $2.22M | Sell |
21,964
-39,428
| -64% | -$4.14M | ﹤0.01% | 3193 |
|
|
2021
Q4 | $6.33M | Buy |
61,392
+18,407
| +43% | +$1.7M | 0.01% | 2127 |
|
|
2021
Q3 | $3.65M | Sell |
42,985
-544,658
| -93% | -$45.6M | ﹤0.01% | 2429 |
|
|
2021
Q2 | $49M | Sell |
587,643
-193,436
| -25% | -$15.8M | 0.04% | 554 |
|
|
2021
Q1 | $58.8M | Sell |
781,079
-956,247
| -55% | -$69.7M | 0.06% | 417 |
|
|
2020
Q4 | $119M | Sell |
1,737,326
-3,139,539
| -64% | -$204M | 0.11% | 222 |
|
|
2020
Q3 | $285M | Buy |
4,876,865
+1,509,271
| +45% | +$93.9M | 0.29% | 49 |
|
|
2020
Q2 | $219M | Sell |
3,367,594
-633,026
| -16% | -$39.9M | 0.26% | 63 |
|
|
2020
Q1 | $237M | Buy |
4,000,620
+3,181,966
| +389% | +$212M | 0.37% | 33 |
|
|
2019
Q4 | $60.8M | Sell |
818,654
-160,577
| -16% | -$11.3M | 0.07% | 326 |
|
|
2019
Q3 | $61.8M | Sell |
979,231
-2,276,747
| -70% | -$135M | 0.08% | 315 |
|
|
2019
Q2 | $177M | Buy |
3,255,978
+1,803,928
| +124% | +$97.1M | 0.22% | 82 |
|
|
2019
Q1 | $78.3M | Sell |
1,452,050
-161,590
| -10% | -$9.97M | 0.1% | 238 |
|
|
2018
Q4 | $106M | Buy |
1,613,640
+585,186
| +57% | +$43.7M | 0.15% | 157 |
|
|
2018
Q3 | $81M | Buy |
1,028,454
+496,450
| +93% | +$35.5M | 0.1% | 259 |
|
|
2018
Q2 | $34.2M | Sell |
532,004
-405,452
| -43% | -$26.7M | 0.04% | 487 |
|
|
2018
Q1 | $58.3M | Buy |
937,456
+322,983
| +53% | +$23.2M | 0.08% | 304 |
|
|
2017
Q4 | $44.5M | Buy |
614,473
+107,254
| +21% | +$7.8M | 0.06% | 386 |
|
|
2017
Q3 | $41.2M | Buy |
507,219
+268,095
| +112% | +$21.2M | 0.06% | 369 |
|
|
2017
Q2 | $19.2M | Sell |
239,124
-144,021
| -38% | -$11.4M | 0.03% | 602 |
|
|
2017
Q1 | $30.1M | Sell |
383,145
-1,719,876
| -82% | -$137M | 0.05% | 425 |
|
|
2016
Q4 | $166M | Sell |
2,103,021
-4,827,644
| -70% | -$391M | 0.28% | 61 |
|
|
2016
Q3 | $617M | Buy |
6,930,665
+1,523,053
| +28% | +$144M | 1.09% | 3 |
|
|
2016
Q2 | $518M | Buy |
5,407,612
+5,383,276
| +22,121% | +$537M | 0.95% | 2 |
|
|
2016
Q1 | $2.52M | Sell |
24,336
-495,147
| -95% | -$48.1M | ﹤0.01% | 1725 |
|
|
2015
Q4 | $50.8M | Sell |
519,483
-346,905
| -40% | -$34M | 0.08% | 309 |
|
|
2015
Q3 | $83.6M | Buy |
866,388
+280,273
| +48% | +$29.5M | 0.12% | 190 |
|
|
2015
Q2 | $61.5M | Buy |
586,115
+111,434
| +23% | +$11.4M | 0.09% | 259 |
|
|
2015
Q1 | $49M | Sell |
474,681
-85,164
| -15% | -$8.62M | 0.08% | 310 |
|
|
2014
Q4 | $53.9M | Buy |
559,845
+545,802
| +3,887% | +$48.1M | 0.07% | 333 |
|
|
2014
Q3 | $1.12M | Sell |
14,043
-870,004
| -98% | -$68.6M | ﹤0.01% | 2704 |
|
|
2014
Q2 | $66.6M | Buy |
+884,047
| New | +$66.8M | 0.09% | 250 |
|
|
2014
Q1 | – | Sell |
-688,002
| Closed | -$48.6M | – | 4335 |
|
|
2013
Q4 | $49.2M | Sell |
688,002
-454,603
| -40% | -$29.2M | 0.07% | 320 |
|
|
2013
Q3 | $64.8M | Buy |
1,142,605
+114,989
| +11% | +$6.85M | 0.1% | 200 |
|
|
2013
Q2 | $58.8M | Buy |
+1,027,616
| New | +$59.5M | 0.11% | 189 |
|
Other funds holding CVS
VCM
VPM
D.E. Shaw & Co's CVS Position: Q1 2026 in Review
D.E. Shaw & Co increased its CVS Health (CVS) stake by 50% in Q1 2026, buying an estimated $41.8M and bringing the position to 1,617,522 shares worth $116M. The position accounts for 0.07% of the portfolio, ranked #325.
D.E. Shaw & Co first reported a position in CVS in Q2 2013 and has held it in 51 quarters since. The position peaked at $617M in Q3 2016. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- D.E. Shaw & Co held 1,617,522 shares of CVS Health worth $116M as of Q1 2026.
- D.E. Shaw & Co bought 542,634 CVS Health shares in Q1 2026, an estimated $41.8M.
- CVS Health made up 0.07% of D.E. Shaw & Co's portfolio in Q1 2026, its #325 holding.
- D.E. Shaw & Co first reported a position in CVS Health in Q2 2013 and has held it in 51 quarters since.
- D.E. Shaw & Co's CVS Health position peaked at $617M in Q3 2016.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.